REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/13/2026
Back to search
Official data from USPTO
CYTOKINE CIRCUIT SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CYTOKINE CIRCUIT SOLUTIONS
ST13
US500000088924258Class
5
Filing
88924258
Registration
6414392
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
07/13/2026
Trademark type
Word
Nice classes
5
Filing date
05/20/2020
Registration date
07/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/13/2021
Last transaction
07/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/05/2012
First use in commerce
09/05/2012
Drawing code
4
Owner type
01
Owner location
Murrieta, CA, US
Examiner
RICHARDS, LESLIE
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Radentz, Leslie Marie
Representatives
Owen J. Bates LAW OFFICE OF OWEN BATES
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal herbal preparation to soothe the manifest appearance of inflammatory cytokines of the skin
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/13/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/27/2021
PUBO
PUBLISHED FOR OPPOSITION
04/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/26/2020
GNRT
NON-FINAL ACTION E-MAILED
08/26/2020
CNRT
NON-FINAL ACTION WRITTEN
08/26/2020
DOCK
ASSIGNED TO EXAMINER
08/19/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/10/2020
Continuous trademark protection
Get notified about every new filing that threatens CYTOKINE CIRCUIT SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.